2.64
price up icon7.76%   0.19
 
loading
Precedente Chiudi:
$2.45
Aprire:
$2.46
Volume 24 ore:
307.26K
Relative Volume:
2.46
Capitalizzazione di mercato:
$24.15M
Reddito:
$2.05M
Utile/perdita netta:
$-27.28M
Rapporto P/E:
-0.4583
EPS:
-5.76
Flusso di cassa netto:
$-18.89M
1 W Prestazione:
+15.79%
1M Prestazione:
-8.65%
6M Prestazione:
+17.33%
1 anno Prestazione:
+896.23%
Intervallo 1D:
Value
$2.43
$2.82
Intervallo di 1 settimana:
Value
$2.08
$2.82
Portata 52W:
Value
$0.20
$4.98

iBio Inc Stock (IBIO) Company Profile

Name
Nome
iBio Inc
Name
Telefono
302-355-0650
Name
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Name
Dipendente
54
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
IBIO's Discussions on Twitter

Confronta IBIO con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
IBIO 2.64 24.15M 2.05M -27.28M -18.89M -5.76
VRTX 450.97 116.14B 10.63B -479.80M -1.35B 13.33
REGN 738.00 81.10B 13.85B 4.65B 3.32B 35.06
ARGX 605.92 36.23B 1.86B -40.29M -1.28B -4.16
ALNY 244.89 31.59B 2.09B -332.26M 16.06M -4.14
BNTX 113.13 27.12B 3.30B -501.07M 1.03B 11.54

iBio Inc Stock (IBIO) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2021-11-29 Iniziato JMP Securities Mkt Outperform
2021-01-22 Iniziato Cantor Fitzgerald Overweight
2020-06-26 Iniziato Alliance Global Partners Buy

iBio Inc Borsa (IBIO) Ultime notizie

pulisher
Nov 22, 2024

iBio Inc. stock rises Friday, outperforms market - MarketWatch

Nov 22, 2024
pulisher
Nov 21, 2024

iBio Inc. stock rises Thursday, outperforms market - MarketWatch

Nov 21, 2024
pulisher
Nov 20, 2024

iBio Inc. stock falls Wednesday, underperforms market - MarketWatch

Nov 20, 2024
pulisher
Nov 19, 2024

iBio Inc. stock rises Tuesday, outperforms market - MarketWatch

Nov 19, 2024
pulisher
Nov 15, 2024

Ikarian Capital, LLC Adjusts Stake in iBio Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

ADAR1 Capital Management's Strategic Acquisition in iBio Inc - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

iBio Inc. stock falls Thursday, underperforms market - MarketWatch

Nov 14, 2024
pulisher
Nov 12, 2024

iBio Inc Reports Fiscal Q1 GAAP EPS of -$0.52, Missing Estimates; No Revenue Reported, Aligning with Expectations - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Nov 12, 2024
pulisher
Nov 12, 2024

iBio Reports Fiscal First Quarter 2025 Financial Results - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

iBio (NYSE:IBIO) Trading Down 0.6% – Here’s What Happened - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

iBio Inc. stock remains steady Monday, underperforms market - MarketWatch

Nov 11, 2024
pulisher
Oct 28, 2024

iBio Inc. stock rises Monday, outperforms market - MarketWatch

Oct 28, 2024
pulisher
Oct 23, 2024

iBio Unveils AI-Driven Antibody Discovery Strategy - TipRanks

Oct 23, 2024
pulisher
Oct 21, 2024

Plant-Based Vaccines Market Is Booming Worldwide 2024-2031 | - openPR

Oct 21, 2024
pulisher
Oct 17, 2024

iBio Inc. stock remains steady Thursday, underperforms market - MarketWatch

Oct 17, 2024
pulisher
Oct 16, 2024

iBio Inc. stock rises Wednesday, outperforms market - MarketWatch

Oct 16, 2024
pulisher
Oct 14, 2024

iBio Inc. stock falls Monday, underperforms market - MarketWatch

Oct 14, 2024
pulisher
Oct 14, 2024

Biopharmaceuticals Contract Manufacturing Industry Research 2024-2030: Biopharma Giants Increasingly Outsource to Streamline Drug Developments - GlobeNewswire Inc.

Oct 14, 2024
pulisher
Oct 11, 2024

Lead molecule identified under Ibio and Astralbio’s myostatin program for obesity - BioWorld Online

Oct 11, 2024
pulisher
Oct 11, 2024

Items Tagged with 'Astralbio Inc.' - BioWorld Online

Oct 11, 2024
pulisher
Oct 10, 2024

iBio and AstralBio Provide Update on Myostatin Program for Obesity - GlobeNewswire

Oct 10, 2024
pulisher
Oct 10, 2024

IBio, Inc. and AstralBio Provide Update on Myostatin Program for Obesity - Marketscreener.com

Oct 10, 2024
pulisher
Oct 08, 2024

IBIO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Oct 08, 2024
pulisher
Oct 07, 2024

What is going on with iBio Inc? Sentiment Analysis - US Post News

Oct 07, 2024
pulisher
Oct 04, 2024

iBio Inc. stock falls Friday, underperforms market - MarketWatch

Oct 04, 2024
pulisher
Sep 26, 2024

iBio (NYSE:IBIO) Trading 1.6% Higher - Defense World

Sep 26, 2024
pulisher
Sep 24, 2024

Inogen: Upside Seems Limited After Big Move Up (NASDAQ:INGN) - Seeking Alpha

Sep 24, 2024
pulisher
Sep 24, 2024

Biafra: Why We Ended Nnamdi Kanu’s Trial – Lawyer Ejimakor - Tori.ng

Sep 24, 2024
pulisher
Sep 24, 2024

Analytical Overview: ImmunityBio Inc (IBRX)’s Ratios Tell a Financial Story - The Dwinnex

Sep 24, 2024

iBio Inc Azioni (IBIO) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$71.72
price up icon 1.89%
$19.00
price up icon 3.15%
$41.11
price up icon 7.48%
$372.89
price up icon 1.51%
$190.51
price down icon 2.08%
$113.13
price up icon 4.53%
Capitalizzazione:     |  Volume (24 ore):